Learn More
Medchemexpress LLC MTX-531 | 2791417-66-6 | 99.9% | 453.94 | 5 MG

Supplier: Medchemexpress LLC HY1627135MG
MTX-531 is an oral drug that inhibits EGFR and PI3K isoforms (PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ). It has anti-tumor effects and acts as a weak agonist of PPARγ, which helps mitigate hyperglycemia often induced by PI3K inhibitors. It shows excellent tolerance in mice and has demonstrated concentration-dependent inhibitory effects on EGFR, P13K, and mTOR in CAL-33 cells.
- Inhibits EGFR and PI3K isoforms
- Acts as a weak agonist of PPARγ, alleviating PI3K inhibitor-induced hyperglycemia
- Demonstrates anti-tumor activity in various models
- Administered orally
- Shows excellent tolerance in mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.